Skip to Main Content

Paper Details

A molecularly integrated grade for meningioma.
Neuro Oncol
91
2022
CDKN2A, Meningioma, Meningiomas, chromosomal, chromosome 1p, 3p, 4, 6, 10, 14q, 18, 19, meningioma, meningiomas, patient, patients, primary intracranial tumor
Author NameAffiliation
Varun M BhaveBrigham and Women's Hospital, Harvard Medical School
Farshad NassiriUniversity of Toronto
Kenneth AldapeNational Cancer Institute
Kenneth AldapeNational Cancer Institute
Gelareh ZadehUniversity of Toronto
Abrar ChoudhuryUniversity of California San Francisco
Abrar ChoudhuryUniversity of California San Francisco
Harish N VasudevanUniversity of California San Francisco
Harish N VasudevanUniversity of California San Francisco
Stephen T MagillUniversity of California San Francisco
Stephen T MagillUniversity of California San Francisco
David R RaleighUniversity of California San Francisco
David R RaleighUniversity of California San Francisco
Malak AbedalthagafiKing Fahad Medical City and King Abdulaziz City for Science and Technology
Keith L LigonBrigham and Women's Hospital, Harvard Medical School
Patrick Y WenCenter for Neuro-Oncology, Dana-Farber Cancer Institute
Azra H LigonBrigham and Women's Hospital, Harvard Medical School
Adrian M DubucBrigham and Women's Hospital, Harvard Medical School
Rameen BeroukhimCenter for Neuro-Oncology, Dana-Farber Cancer Institute
Rameen BeroukhimDana-Farber Cancer Institute
Rameen BeroukhimBroad Institute of MIT and Harvard
Ian F DunnOklahoma University Medical Center
Sandro SantagataBrigham and Women's Hospital, Harvard Medical School
Wenya Linda BiBrigham and Women's Hospital, Harvard Medical School
Wenya Linda BiDana-Farber Cancer Institute
  • 1 - 25

Datasets

Release 1.2